LIFECORE BIOMEDICAL, INC. Operating Cash Flow
LIFECORE BIOMEDICAL, INC. (LFCR) reported Operating Cash Flow of $2.51 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- LIFECORE BIOMEDICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$2.19M.
- LIFECORE BIOMEDICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $4.70M.
- LIFECORE BIOMEDICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $1.76M.
- LIFECORE BIOMEDICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2025-05-25 was $5.35M, a 38.63% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$206.00K, a 180.16% decline from fiscal 2024.
- LIFECORE BIOMEDICAL, INC. net cash provided by (used in) operating activities for fiscal 2024 was $257.00K.
- LIFECORE BIOMEDICAL, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$17.44M.
- LIFECORE BIOMEDICAL, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$22.59M, a 237.17% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 7 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.51M 10-Q · filed 2026-08-05 | |||||||
| 2026-03-31 | $4.70M 10-Q · filed 2026-05-06 | ||||||||
| 2025-12-31 | $7.33M 10-KT · filed 2026-03-16 | ||||||||
| 2025-09-30 | $1.76M 10-Q · filed 2025-11-06 | ||||||||
| 2025-05-25 | $5.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $6.55M 10-Q · filed 2026-08-05 | $408.00K derived: sum of 3 quarters · filed 2026-08-05 | -$206.00K 10-KT · filed 2026-03-16 | |||||
| 2025-02-23 | $1.20M 10-Q · filed 2026-05-06 | -$4.94M derived: sum of 2 quarters · filed 2026-05-06 | -$5.55M 10-Q · filed 2025-04-03 | $3.16M derived: sum of 4 quarters · filed 2026-05-06 | |||||
| 2024-11-24 | -$6.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-02 | -$6.75M 10-Q · filed 2025-01-02 | $1.96M derived: sum of 3 quarters · filed 2026-03-16 | $545.00K derived: sum of 4 quarters · filed 2026-03-16 | |||||
| 2024-08-25 | -$613.00K 10-Q · filed 2025-11-06 | -$643.00K 10-Q · filed 2024-10-04 | $8.10M derived: sum of 2 quarters · filed 2026-03-16 | $6.68M derived: sum of 3 quarters · filed 2026-03-16 | $7.97M derived: sum of 4 quarters · filed 2026-03-16 | ||||
| 2024-05-26 | $8.72M derived: 10-KT 12 month − 10-Q 9 month · filed 2026-03-16 | $7.30M derived: sum of 2 quarters · filed 2026-03-16 | $8.59M derived: sum of 3 quarters · filed 2026-03-16 | $257.00K 10-KT · filed 2026-03-16 | -$217.00K 10-K · filed 2024-08-26 | ||||
| 2024-02-25 | -$1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-03 | -$130.00K derived: sum of 2 quarters · filed 2025-04-03 | -$8.46M 10-Q · filed 2025-04-03 | -$8.86M 10-Q · filed 2024-08-09 | -$10.72M derived: sum of 4 quarters · filed 2025-04-03 | ||||
| 2023-11-26 | $1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-02 | -$7.04M 10-Q · filed 2025-01-02 | -$7.32M 10-Q · filed 2024-08-09 | -$9.30M derived: sum of 3 quarters · filed 2025-01-02 | -$21.03M derived: sum of 4 quarters · filed 2025-01-02 | ||||
| 2023-08-27 | -$8.33M 10-Q · filed 2024-10-04 | -$10.59M derived: sum of 2 quarters · filed 2024-10-04 | -$22.32M derived: sum of 3 quarters · filed 2024-10-04 | -$24.67M derived: sum of 4 quarters · filed 2024-10-04 | |||||
| 2023-05-28 | -$2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26 | -$13.99M derived: sum of 2 quarters · filed 2024-08-26 | -$16.34M derived: sum of 3 quarters · filed 2024-08-26 | -$17.44M 10-K · filed 2024-08-26 | |||||
| 2023-02-26 | -$11.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | -$14.08M derived: sum of 2 quarters · filed 2024-08-09 | -$15.18M 10-Q · filed 2024-08-09 | -$17.17M 10-Q · filed 2023-06-02 | -$17.03M derived: sum of 4 quarters · filed 2024-08-26 | ||||
| 2022-11-27 | -$2.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$3.45M 10-Q · filed 2024-08-09 | -$4.48M 10-Q · filed 2023-03-16 | -$5.31M derived: sum of 3 quarters · filed 2024-08-26 | -$22.62M derived: sum of 4 quarters · filed 2024-08-26 | ||||
| 2022-08-28 | -$1.10M 10-Q · filed 2024-08-09 | -$1.53M 10-Q · filed 2022-10-07 | -$2.95M derived: sum of 2 quarters · filed 2024-08-26 | -$20.26M derived: sum of 3 quarters · filed 2024-08-26 | -$25.07M derived: sum of 4 quarters · filed 2024-08-26 | ||||
| 2022-05-29 | -$1.85M derived: 10-K 12 month − 10-K 9 month · filed 2024-08-26 | -$19.16M derived: sum of 2 quarters · filed 2024-08-26 | -$23.97M derived: sum of 3 quarters · filed 2024-08-26 | -$22.59M 10-K · filed 2024-08-26 | -$24.40M 10-K · filed 2022-09-14 | ||||
| 2022-02-27 | -$17.31M derived: 10-K 9 month − 10-K 6 month · filed 2024-03-20 | -$22.12M derived: sum of 2 quarters · filed 2024-03-20 | -$20.74M 10-K · filed 2024-03-20 | -$24.43M 10-Q · filed 2022-04-07 | -$15.66M derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2021-11-28 | -$4.81M derived: 10-K 6 month − 10-K 3 month · filed 2024-03-20 | -$3.43M 10-K · filed 2024-03-20 | -$4.31M 10-Q · filed 2022-01-07 | $1.65M derived: sum of 3 quarters · filed 2024-03-20 | -$5.42M derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2021-08-29 | $1.38M 10-K · filed 2024-03-20 | $831.00K 10-Q · filed 2021-10-05 | $6.46M derived: sum of 2 quarters · filed 2024-03-20 | -$606.00K derived: sum of 3 quarters · filed 2024-03-20 | $624.00K derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2021-05-30 | $5.08M derived: 10-K 12 month − 10-K 9 month · filed 2024-03-20 | -$1.99M derived: sum of 2 quarters · filed 2024-03-20 | -$755.00K derived: sum of 3 quarters · filed 2024-03-20 | $16.47M 10-K · filed 2024-03-20 | $15.02M 10-K · filed 2021-07-29 | ||||
| 2021-02-28 | -$7.07M derived: 10-K 9 month − 10-Q 6 month · filed 2024-03-20 | -$5.84M derived: sum of 2 quarters · filed 2024-03-20 | $11.39M 10-K · filed 2024-03-20 | $10.60M 10-Q · filed 2021-04-08 | -$1.32M derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2020-11-29 | $1.23M derived: 10-Q 6 month − 10-K 3 month · filed 2022-01-07 | $18.46M 10-Q · filed 2022-01-07 | $5.75M derived: sum of 3 quarters · filed 2024-03-20 | $16.34M derived: sum of 4 quarters · filed 2024-03-20 | |||||
| 2020-08-30 | $17.23M 10-K · filed 2024-03-20 | $17.02M 10-Q · filed 2020-10-07 | $4.52M derived: sum of 2 quarters · filed 2024-03-20 | $15.11M derived: sum of 3 quarters · filed 2024-03-20 | $5.62M derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2020-05-31 | -$12.70M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16 | -$2.12M derived: sum of 2 quarters · filed 2023-03-16 | -$11.60M derived: sum of 3 quarters · filed 2023-03-16 | -$17.04M 10-K/A · filed 2023-03-16 | |||||
| 2020-02-23 | $10.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-08 | $1.10M derived: sum of 2 quarters · filed 2021-04-08 | -$4.34M 10-Q · filed 2021-04-08 | -$5.77M derived: sum of 4 quarters · filed 2021-07-29 | |||||
| 2019-11-24 | -$9.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-07 | -$14.92M 10-Q · filed 2021-01-07 | -$16.35M derived: sum of 3 quarters · filed 2021-07-29 | -$3.71M derived: sum of 4 quarters · filed 2021-07-29 | |||||
| 2019-08-25 | -$5.44M 10-Q · filed 2020-10-07 | -$6.87M derived: sum of 2 quarters · filed 2021-07-29 | $5.78M derived: sum of 3 quarters · filed 2021-07-29 | $8.39M derived: sum of 4 quarters · filed 2021-07-29 | |||||
| 2019-05-26 | -$1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29 | $11.22M derived: sum of 2 quarters · filed 2021-07-29 | $13.83M derived: sum of 3 quarters · filed 2021-07-29 | $16.02M 10-K · filed 2021-07-29 | |||||
| 2019-02-24 | $12.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | $15.26M derived: sum of 2 quarters · filed 2020-04-03 | $17.45M 10-Q · filed 2020-04-03 | $16.93M derived: sum of 4 quarters · filed 2020-08-14 | |||||
| 2018-11-25 | $2.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-02 | $4.80M 10-Q · filed 2020-01-02 | $4.28M derived: sum of 3 quarters · filed 2020-08-14 | $24.58M derived: sum of 4 quarters · filed 2020-08-14 | |||||
| 2018-08-26 | $2.19M 10-Q · filed 2019-10-03 | $1.67M derived: sum of 2 quarters · filed 2020-08-14 | $21.96M derived: sum of 3 quarters · filed 2020-08-14 | $28.30M derived: sum of 4 quarters · filed 2020-08-14 | |||||
| 2018-05-27 | -$521.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | $19.78M derived: sum of 2 quarters · filed 2020-08-14 | $26.11M derived: sum of 3 quarters · filed 2020-08-14 | $19.78M 10-K · filed 2020-08-14 | |||||
| 2018-02-25 | $20.30M 10-K · filed 2018-08-09 | $26.64M derived: sum of 2 quarters · filed 2018-08-09 | $20.30M 10-Q · filed 2019-04-04 | $18.10M 10-Q · filed 2018-04-05 | $36.74M derived: sum of 4 quarters · filed 2019-08-01 | ||||
| 2017-11-26 | $6.34M 10-K · filed 2018-08-09 | $6.34M 10-Q · filed 2019-01-07 | $4.33M 10-Q · filed 2018-01-05 | $16.44M derived: sum of 3 quarters · filed 2019-08-01 | $43.07M derived: sum of 4 quarters · filed 2019-08-01 | ||||
| 2017-08-27 | $3.45M 10-Q · filed 2018-10-05 | $10.11M derived: sum of 2 quarters · filed 2019-08-01 | $36.73M derived: sum of 3 quarters · filed 2019-08-01 | $46.45M derived: sum of 4 quarters · filed 2019-08-01 | |||||
| 2017-05-28 | $6.66M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01 | $33.28M derived: sum of 2 quarters · filed 2019-08-01 | $42.99M derived: sum of 3 quarters · filed 2019-08-01 | $29.84M 10-K · filed 2019-08-01 | $29.74M 10-K · filed 2018-08-09 | ||||
| 2017-02-26 | $26.63M 10-K · filed 2018-08-09 | $36.34M derived: sum of 2 quarters · filed 2018-08-09 | $23.18M 10-Q · filed 2018-04-05 | ||||||
| 2016-11-27 | $9.71M 10-K · filed 2018-08-09 | $5.53M 10-Q · filed 2018-01-05 | |||||||
| 2016-08-28 | $9.97M 10-K · filed 2018-08-09 | ||||||||
| 2016-05-29 | $20.76M 10-K · filed 2018-08-09 | ||||||||
| 2014-02-23 | $9.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28 | $9.30M derived: sum of 2 quarters · filed 2014-03-28 | $13.83M 10-Q · filed 2014-03-28 | $21.59M derived: sum of 4 quarters · filed 2014-03-28 | |||||
| 2013-11-24 | -$245.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03 | $4.29M 10-Q · filed 2014-01-03 | $12.05M derived: sum of 3 quarters · filed 2014-01-03 | $23.14M derived: sum of 4 quarters · filed 2014-03-28 | |||||
| 2013-08-25 | $4.54M 10-Q · filed 2013-09-26 | $12.29M derived: sum of 2 quarters · filed 2013-09-26 | $23.38M derived: sum of 3 quarters · filed 2014-03-28 | $20.68M derived: sum of 4 quarters · filed 2014-03-28 | |||||
| 2013-05-26 | $7.75M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $18.85M derived: sum of 2 quarters · filed 2014-03-28 | $16.14M derived: sum of 3 quarters · filed 2014-03-28 | $21.23M 10-K · filed 2013-08-07 | |||||
| 2013-02-24 | $11.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28 | $8.39M derived: sum of 2 quarters · filed 2014-03-28 | $13.47M 10-Q · filed 2014-03-28 | $27.12M derived: sum of 4 quarters · filed 2014-03-28 | |||||
| 2012-11-25 | -$2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03 | $2.38M 10-Q · filed 2014-01-03 | $16.03M derived: sum of 3 quarters · filed 2014-01-03 | $25.31M derived: sum of 4 quarters · filed 2014-01-03 | |||||
| 2012-08-26 | $5.08M 10-Q · filed 2013-09-26 | $18.73M derived: sum of 2 quarters · filed 2013-09-26 | $28.01M derived: sum of 3 quarters · filed 2013-09-26 | $22.91M derived: sum of 4 quarters · filed 2013-09-26 | |||||
| 2012-05-27 | $13.65M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $22.92M derived: sum of 2 quarters · filed 2013-08-07 | $17.82M derived: sum of 3 quarters · filed 2013-08-07 | $22.18M 10-K · filed 2013-08-07 | |||||
| 2012-02-26 | $9.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-04 | $4.18M derived: sum of 2 quarters · filed 2013-04-04 | $8.54M 10-Q · filed 2013-04-04 | $10.57M derived: sum of 4 quarters · filed 2013-08-07 | |||||
| 2011-11-27 | -$5.10M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-04 | -$742.00K 10-Q · filed 2013-01-04 | $1.29M derived: sum of 3 quarters · filed 2013-08-07 | ||||||
| 2011-08-28 | $4.36M 10-Q/A · filed 2013-01-02 | $6.39M derived: sum of 2 quarters · filed 2013-08-07 | |||||||
| 2011-05-29 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $14.47M 10-K · filed 2013-08-07 | |||||||
| 2011-02-27 | $12.43M 10-Q · filed 2012-03-28 | ||||||||
| 2010-11-28 | $2.07M 10-Q · filed 2012-01-05 | ||||||||
| 2010-08-29 | $4.38M 10-Q · filed 2011-10-05 | ||||||||
| 2010-05-30 | $7.48M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |